HomeMARKSANS • NSE
add
Marksans Pharma Ltd
Previous close
₹167.60
Day range
₹163.45 - ₹169.45
Year range
₹70.55 - ₹185.50
Market cap
75.25B INR
Avg Volume
2.25M
P/E ratio
23.56
Dividend yield
0.30%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 5.86B | 22.15% |
Operating expense | 2.02B | 14.65% |
Net income | 832.35M | 33.59% |
Net profit margin | 14.20 | 9.40% |
Earnings per share | 1.84 | — |
EBITDA | 1.19B | 69.42% |
Effective tax rate | 26.36% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 6.61B | 97.12% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 18.97B | — |
Shares outstanding | 452.36M | — |
Price to book | 4.06 | — |
Return on assets | — | — |
Return on capital | 13.82% | — |
Cash Flow
Net change in cash
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 832.35M | 33.59% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1992
Website
Employees
852